With respect to cutaneous manifestation of SSc, 85.2% of patients positive for S1PR1-aAb had a limited cutaneous form, whereas the diffuse manifestations were dominating in patients that were positive for S1PR2-aAb or S1PR3-aAb. This evidence concerns the gene S1PR3 and systemic sclerosis.